These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. Effects of Intermittent Treatment with Topical Corticosteroids and Calcineurin Inhibitors on Epidermal and Dermal Thickness Using Optical Coherence Tomography and Ultrasound. Aschoff R, Lang A, Koch E. Skin Pharmacol Physiol; 2022 Sep; 35(1):41-50. PubMed ID: 34348352 [Abstract] [Full Text] [Related]
38. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Kragballe K, Barnes L, Hamberg KJ, Hutchinson P, Murphy F, Møller S, Ruzicka T, Van De Kerkhof PC. Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908 [Abstract] [Full Text] [Related]
39. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. McMichael AJ, Griffiths CE, Talwar HS, Finkel LJ, Rafal ES, Hamilton TA, Voorhees JJ. Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360 [Abstract] [Full Text] [Related]
40. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test. Snape SD, Wigger-Alberti W, Goehring UM. Br J Dermatol; 2016 Sep; 175(3):479-86. PubMed ID: 27038440 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]